<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">23738005</PMID>
      <DateCompleted>
        <Year>2014</Year>
        <Month>01</Month>
        <Day>10</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2021</Year>
        <Month>10</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Electronic-Print">
        <Journal>
          <ISSN IssnType="Electronic">1932-6203</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>8</Volume>
            <Issue>5</Issue>
            <PubDate>
              <Year>2013</Year>
            </PubDate>
          </JournalIssue>
          <Title>PloS one</Title>
          <ISOAbbreviation>PLoS One</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Vagal afferent mediates the anorectic effect of peripheral secretin.</ArticleTitle>
        <Pagination>
          <StartPage>e64859</StartPage>
          <MedlinePgn>e64859</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="pii" ValidYN="Y">e64859</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0064859</ELocationID>
        <Abstract>
          <AbstractText>Secretin (SCT) is a classical peptide hormone that is synthesized and released from the gastrointestinal tract after a meal. We have previously shown that it acts both as a central and peripheral anorectic peptide, and that its central effect is mediated via melanocortin system. As peripheral satiety signals from the gastrointestinal tract can be sent to the brain via the vagal afferent or by crossing the blood-brain barrier (BBB), we therefore sought to investigate the pathway by which peripheral SCT reduces appetite in this study. It is found that bilateral subdiaphragmatic vagotomy and treatment of capsaicin, an excitotoxin for primary afferent neurons, could both block the anorectic effect of peripherally injected SCT. These treatments are found to be capable of blunting i.p. SCT-induced Fos activation in pro-opiomelanocortin (POMC) neurons within the hypothalamic Arcuate Nucleus (Arc). Moreover, we have also found that bilateral midbrain transaction could block feeding reduction by peripheral SCT. Taken together, we conclude that the satiety signals of peripheral SCT released from the gastrointestinal tract are sent via the vagus nerves to the brainstem and subsequently Arc, where it controls central expression of other regulatory peptides to regulate food intake.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Chu</LastName>
            <ForeName>Jessica Y S</ForeName>
            <Initials>JY</Initials>
            <AffiliationInfo>
              <Affiliation>School of Biological Sciences, The University of Hong Kong, Pokfulam, Hong Kong SAR, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Cheng</LastName>
            <ForeName>Carrie Y Y</ForeName>
            <Initials>CY</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sekar</LastName>
            <ForeName>Revathi</ForeName>
            <Initials>R</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chow</LastName>
            <ForeName>Billy K C</ForeName>
            <Initials>BK</Initials>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2013</Year>
          <Month>05</Month>
          <Day>30</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>PLoS One</MedlineTA>
        <NlmUniqueID>101285081</NlmUniqueID>
        <ISSNLinking>1932-6203</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D001067">Appetite Depressants</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>1393-25-5</RegistryNumber>
          <NameOfSubstance UI="D012633">Secretin</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>66796-54-1</RegistryNumber>
          <NameOfSubstance UI="D011333">Pro-Opiomelanocortin</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001067" MajorTopicYN="N">Appetite Depressants</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001933" MajorTopicYN="N">Brain Stem</DescriptorName>
          <QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName>
          <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
          <QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004435" MajorTopicYN="N">Eating</DescriptorName>
          <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009475" MajorTopicYN="N">Neurons, Afferent</DescriptorName>
          <QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName>
          <QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
          <QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011333" MajorTopicYN="N">Pro-Opiomelanocortin</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012633" MajorTopicYN="N">Secretin</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014630" MajorTopicYN="N">Vagus Nerve</DescriptorName>
          <QualifierName UI="Q000166" MajorTopicYN="Y">cytology</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <CoiStatement><b>Competing Interests: </b>The authors have declared that no competing interests exist.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2012</Year>
          <Month>3</Month>
          <Day>9</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2013</Year>
          <Month>4</Month>
          <Day>23</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2013</Year>
          <Month>6</Month>
          <Day>6</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2013</Year>
          <Month>6</Month>
          <Day>6</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2014</Year>
          <Month>1</Month>
          <Day>11</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">23738005</ArticleId>
        <ArticleId IdType="pmc">PMC3667839</ArticleId>
        <ArticleId IdType="doi">10.1371/journal.pone.0064859</ArticleId>
        <ArticleId IdType="pii">PONE-D-12-07188</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>
Vaudry D, Gonzalez BJ, Basille M, Yon L, Fournier A, et al. (2000) Pituitary adenylate cyclase-activating polypeptide and its receptors: from structure to functions. Pharmacol Rev
52: 269–324.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10835102</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Gerber JG, Payne NA (1996) Secretin inhibits canine gastric acid secretion in response to pentagastrin by modulating gastric histamine release. J Pharmacol Exp Ther
279: 718–723.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8930176</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Jin HO, Lee KY, Chang TM, Chey WY, Dubois A (1994) Secretin: a physiological regulator of gastric emptying and acid output in dogs. Am J Physiol
267: G702–G708.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">7943335</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Shiratori K, Watanabe S, Takeuchi T (1992) Role of endogenous secretin and cholecystokinin in intraduodenal oleic acid-induced inhibition of gastric acid secretion in rats. Dig Dis Sci
37: 397–402.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1735364</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
You CH, Chey WY (1987) Secretin is an enterogastrone in humans. Dig Dis Sci
32: 466–471
doi:10.1007/BF01296028
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/BF01296028</ArticleId>
            <ArticleId IdType="pubmed">2952476</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Gray MA, Greenwell JR, Argent BE (1988) Secretin-regulated chloride channel on the apical plasma membrane of pancreatic duct cells. J Membr Biol
105: 131–142.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2464063</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Konturek SJ, Zabielski R, Konturek JW, Czarnecki J (2003) Neuroendocrinology of the pancreas; role of brain-gut axis in pancreatic secretion. Eur J Pharmacol
481: 1–14.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14637169</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bayliss WM, Starling EH (1902) The mechanism of pancreatic secretion. J Physiol (Lond).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1540572</ArticleId>
            <ArticleId IdType="pubmed">16992627</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Kanno N, LeSage G, Glaser S, Alpini G (2001) Regulation of cholangiocyte bicarbonate secretion. Am J Physiol Gastrointest Liver Physiol
281: G612–G625.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11518673</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Chey WY, Lee YH, Hendricks JG, Rhodes RA, Tai HH (1978) Plasma secretin concentrations in fasting and postprandial state in man. Am J Dig Dis
23: 981–988.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31087</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Katada N, Noda A, Hayakawa T (1983) Postprandial Pancreatic-Secretion and Plasma Hormones in Dogs with Pancreatic Fistula. Am J Gastroenterol
78: 740–744.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">6637965</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Kim MS, Lee KY, Chey WY (1979) Plasma Secretin Concentrations in Fasting and Postprandial States in Dog. Am J Physiol
236: E539–E544.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">35981</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Lee KY, Millikan L, Nishiwaki H, Kim YC, Chang TM, et al. (1980) 24-Hour Plasma Secretin Level and Pancreatic-Secretion in Dog. Peptides
1: 155–158.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">7243614</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Chu JYS, Lee LTO, Lai CH, Vaudry H, Chan YS, et al. (2009) Secretin as a neurohypophysial factor regulating body water homeostasis. Proc Natl Acad Sci USA
106: 15961–15966
doi:10.1073/pnas.0903695106
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.0903695106</ArticleId>
            <ArticleId IdType="pmc">PMC2747226</ArticleId>
            <ArticleId IdType="pubmed">19805236</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Chu JYS, Yung WH, Chow BKC (2006) Endogenous release of secretin from the hypothalamus. Ann N Y Acad Sci
1070: 196–200
doi:10.1196/annals.1317.012
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1196/annals.1317.012</ArticleId>
            <ArticleId IdType="pubmed">16888165</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Cheng CYY, Chu JYS, Chow BKC (2011) Central and peripheral administration of secretin inhibits food intake in mice through the activation of the melanocortin system. Neuropsychopharmacology
36: 459–471
doi:10.1038/npp.2010.178
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/npp.2010.178</ArticleId>
            <ArticleId IdType="pmc">PMC3055665</ArticleId>
            <ArticleId IdType="pubmed">20927047</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Banks WA, Goulet M, Rusche JR, Niehoff ML, Boismenu R (2002) Differential transport of a secretin analog across the blood-brain and blood-cerebrospinal fluid barriers of the mouse. J Pharmacol Exp Ther
302: 1062–1069
doi:10.1124/jpet.102.036129
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1124/jpet.102.036129</ArticleId>
            <ArticleId IdType="pubmed">12183664</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Yang H, Wang L, Wu SV, Tay J, Goulet M, et al. (2004) Peripheral secretin-induced Fos expression in the rat brain is largely vagal dependent. Neuroscience
128: 131–141
doi:10.1016/j.neuroscience.2004.06.027
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.neuroscience.2004.06.027</ArticleId>
            <ArticleId IdType="pubmed">15450360</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Mikhailova SD, Bebyakova NA, Semushkina TM, Izrailtyan IM, Alipov NN (1990) Role of Myelinated and Nonmyelinated Fibers of the Vagus Nerves in the Development of Ischemic Ventricular-Fibrillation. Bulletin of Experimental Biology and Medicine
109: 849–852.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1699617</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Lu Y, Owyang C (1995) Secretin at physiological doses inhibits gastric motility via a vagal afferent pathway. Am J Physiol
268: G1012–G1016.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">7611400</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chey WY, Chang T (2004) Neural control of the release and action of secretin. Journal of physiology and pharmacology.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15075453</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Li P, Chang TM, Chey WY (1998) Secretin inhibits gastric acid secretion via a vagal afferent pathway in rats. Am J Physiol Gastrointest Liver Physiol
275: G22–G28.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9655680</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Kwon HY, Chang TM, Lee KY, Chey WY (1999) Vagus nerve modulates secretin binding sites in the rat forestomach. Am J Physiol
276: G1052–G1058.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10198350</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Wang LM, Vigna SR, Owyang C (1995) Autoradiographic Visualization of Secretin Receptors on Vagal Afferent-Fibers - Evidence for Receptor Coupling to G-Proteins and Modulation by Protein-Kinase-C. Gastroenterology
108: A1015–A1015.</Citation>
        </Reference>
        <Reference>
          <Citation>
Ricardo JA, Koh ET (1978) Anatomical evidence of direct projections from the nucleus of the solitary tract to the hypothalamus, amygdala, and other forebrain structures in the rat. Brain Res
153: 1–26.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">679038</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Yang B, Goulet M, Boismenu R, Ferguson AV (2004) Secretin depolarizes nucleus tractus solitarius neurons through activation of a nonselective cationic conductance. Am J Physiol Regul Integr Comp Physiol
286: R927–R934
doi:10.1152/ajpregu.00600.2003
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1152/ajpregu.00600.2003</ArticleId>
            <ArticleId IdType="pubmed">14715495</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Ruettimann EB, Arnold M, Hillebrand JJ, Geary N, Langhans W (2009) Intrameal Hepatic Portal and Intraperitoneal Infusions of Glucagon-Like Peptide-1 Reduce Spontaneous Meal Size in the Rat via Different Mechanisms. Endocrinology
150: 1174–1181
doi:10.1210/en.2008-1221
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1210/en.2008-1221</ArticleId>
            <ArticleId IdType="pmc">PMC2654737</ArticleId>
            <ArticleId IdType="pubmed">18948395</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Koda S, Date Y, Murakami N, Shimbara T, Hanada T, et al. (2005) The role of the vagal nerve in peripheral PYY3-36-induced feeding reduction in rats. Endocrinology
146: 2369–2375
doi:10.1210/en.2004-1266
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1210/en.2004-1266</ArticleId>
            <ArticleId IdType="pubmed">15718279</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lutz TA, Althaus J, Rossi R, Scharrer E (1998) Anorectic effect of amylin is not transmitted by capsaicin-sensitive nerve fibers. American Journal of …</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9841487</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Crawley JN, Kiss JZ, Mezey E (1984) Bilateral midbrain transections block the behavioral effects of cholecystokinin on feeding and exploration in rats. Brain Res
322: 316–321.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">6509319</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Smith GP, Jerome C, Cushin BJ, Eterno R, Simansky KJ (1981) Abdominal Vagotomy Blocks the Satiety Effect of Cholecystokinin in the Rat. Science
213: 1036–1037.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">7268408</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Zhang J, Ritter RC (2012) Circulating GLP-1 and CCK-8 reduce food intake by capsaicin-insensitive, nonvagal mechanisms. Am J Physiol Regul Integr Comp Physiol
302: R264–R273
doi:10.1152/ajpregu.00114.2011
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1152/ajpregu.00114.2011</ArticleId>
            <ArticleId IdType="pmc">PMC3349390</ArticleId>
            <ArticleId IdType="pubmed">22031786</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Kastin AJ, Akerstrom V, Pan WH (2002) Interactions of glucagon-like peptide-1 (GLP-1) with the blood-brain barrier. J Mol Neurosci
18: 7–14
doi:–10.1385/JMN:18: 1–2: 07
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1385/JMN:18:1-2:07</ArticleId>
            <ArticleId IdType="pubmed">11931352</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
